Cardioprotective effects and underlying mechanism of Radix Salvia miltiorrhiza and Lignum Dalbergia odorifera in a pig chronic myocardial ischemia model

Lin,Rui; Duan,Jialin; Mu,Fei; Bian,Haixu; Zhao,Meina; Zhou,Min; Li,Yao; Wen,Aidong; Yang,Yong; Xi,Miaomiao

doi:10.3892/ijmm.2018.3844

Cardioprotective effects and underlying mechanism of Radix Salvia miltiorrhiza and Lignum Dalbergia odorifera in a pig chronic myocardial ischemia model

Authors:
- Rui Lin
- Jialin Duan
- Fei Mu
- Haixu Bian
- Meina Zhao
- Min Zhou
- Yao Li
- Aidong Wen
- Yong Yang
- Miaomiao Xi
View Affiliations

Affiliations: Department of Pharmacy, Xijing Hospital, Air Force Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Pharmacy, Xijing Hospital, Air Force Military Medical University, Xi'an, Shaanxi 710032, P.R. China , School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China, Department of Pharmacy, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China
Published online on: August 27, 2018 https://doi.org/10.3892/ijmm.2018.3844
Pages: 2628-2640
Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Traditional Chinese medicines, including Radix Salvia miltiorrhiza (SM) and Lignum Dalbergia odorifera (DO) extracts, have historically been used to treat myocardial ischemia and other cardiovascular diseases. The volatile oil of DO (DOO) is one of the main components of DO. The aim of the present study was to assess the cardioprotective effects and possible underlying mechanisms of SM‑DOO in pigs with ameroid constriction‑induced chronic myocardial ischemia. An ameroid constrictor was placed around the left anterior descending coronary artery of pigs to induce chronic myocardial ischemia. At weeks 2, 6 and 8, myocardial injury markers and blood gas levels were detected. At week 8, coronary angiography, echocardiography and hemodynamics analysis were performed to evaluate myocardial function. Following sacrifice, myocardial tissue was collected and subjected to morphological, histopathological and apoptosis assays. Western blotting was used to detect the protein expression of Bcl‑2 associated X (Bax), Bcl‑2, Akt, phosphorylated (p)‑Akt, glycogen synthase kinase (GSK)‑3β and p‑GSK‑3β. It was revealed that SM‑DOO treatment following chronic myocardial ischemia significantly downregulated the expression of myocardial injury markers, ameliorated myocardial oxygen consumption, increased collateralization, reduced regional cardiac dysfunction and limited the extent of myocardial damage. Furthermore, the results of an apoptosis assay revealed that the apoptosis rate was decreased, the expression of Bax decreased and Bcl‑2 increased, and the ratio of Bcl‑2/Bax was increased. Further experiments indicated that treatment with SM‑DOO increased the phosphorylation of Akt and GSK‑3β. These findings suggest that SM‑DOO treatment ameliorates myocardial injury in a chronic myocardial ischemia model, and that the underlying mechanisms responsible may be associated with the activation of the Akt/GSK‑3β signal pathway. Thus, experimental evidence that SM‑DOO may be an effective drug for the prevention and treatment of chronic myocardial ischemia in clinical applications has been provided.

View Figures

View References

1	Shimokawa H and Yasuda S: Myocardial ischemia: Current concepts and future perspectives. J Cardiol. 52:67–78. 2008. View Article : Google Scholar : PubMed/NCBI
2	Lv Y, Liu X, Yan S, Liang X, Yang Y, Dai W and Zhang W: Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal. 52:129–135. 2010. View Article : Google Scholar : PubMed/NCBI
3	Xu T, Wu X, Chen Q, Zhu S, Liu Y, Pan D, Chen X and Li D: The anti-apoptotic and cardioprotective effects of salvianolic acid a on rat cardiomyocytes following ischemia/reperfusion by DUSP-mediated regulation of the ERK1/2/JNK pathway. PLoS One. 9:e1022922014. View Article : Google Scholar :
4	JianXin C, Xue X, ZhongFeng L, Kuo G, FeiLong Z, ZhiHong L, Xian W and HongCai S: Qishen Yiqi Drop Pill improves cardiac function after myocardial ischemia. Sci Rep. 6:243832016. View Article : Google Scholar : PubMed/NCBI
5	Zhang Y, Shi P, Yao H, Shao Q and Fan X: Metabolite profiling and pharmacokinetics of herbal compounds following oral administration of a cardiovascular multi-herb medicine (Qishen yiqi pills) in rats. Curr Drug Metab. 13:510–523. 2012. View Article : Google Scholar : PubMed/NCBI
6	Wu SD, Wang J, Chen SC, Xu JB, Zheng Q, Yan YF, Wen TM and Tang YR: Effect of Xiangdan Injection on mRNA expression of endothelial vasoactive factors of patients with coronary heart disease and blood stasis. Zhong Xi Yi Jie He Xue Bao. 2:94–96. 2004.In Chinese. View Article : Google Scholar : PubMed/NCBI
7	Wang SX, Luo K, Liang J, Fan F, Li H, Zheng JB and Zheng XH: Metabolomics study on the synergistic interaction between Salvia miltiorrhiza and Lignum dalbergiae odoriferae used as 'Jun-Shi' herbs in a S. miltiorrhiza recipe. Med Chem Res. 20:16–22. 2011. View Article : Google Scholar
8	Sugiyama A, Zhu BM, Takahara A, Satoh Y and Hashimoto K: Cardiac effects of salvia miltiorrhiza/dalbergia odorifer a mixture, an intravenously applicable Chinese medicine widely used for patients with ischemic heart disease in China. Circ J. 66:182–184. 2002. View Article : Google Scholar : PubMed/NCBI
9	Mu F, Duan J, Bian H, Zhai X, Shang P, Lin R, Zhao M, Hu D, Yin Y, Wen A, et al: Metabonomic strategy for the evaluation of Chinese medicine salvia miltiorrhiza and dalbergia odorifera interfering with myocardial ischemia/reperfusion injury in rats. Rejuvenation Res. 20:263–277. 2017. View Article : Google Scholar : PubMed/NCBI
10	Zheng X, Zhao X, Wang S, Luo K, Wei Y and Zheng J: Co-administration of Dalbergia odorifera increased bioavailability of Salvia miltiorrhiza e in rabbits. Am J Chin Med. 35:831–840. 2007. View Article : Google Scholar
11	Zhou L, Zuo Z and Chow MS: Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 45:1345–1359. 2005. View Article : Google Scholar : PubMed/NCBI
12	Liu R, Ye M, Guo H, Bi K and Guo DA: Liquid chromatography/electrospray ionization mass spectrometry for the characterization of twenty-three flavonoids in the extract of Dalbergia odorifera. Rapid Commun Mass Spectrom. 19:1557–1565. 2005. View Article : Google Scholar : PubMed/NCBI
13	Tu J and Song K: Curative effect observation on Xiangdan injection in the treatment of coronary artery disease. Chin Med Pharm. 22:110–111. 2011.In Chinese.
14	Qin F and Huang X: Guanxin II for the management of coronary heart disease. Chin J Integr Med. 15:472–476. 2009. View Article : Google Scholar
15	Mu F, Duan J, Bian H, Yin Y, Zhu Y, Wei G, Guan Y, Wang Y, Guo C, Wen A, et al: Cardioprotective effects and mechanism of Radix Salviae miltiorrhizae and Lignum Dalbergiae odoriferae on rat myocardial ischemia/reperfusion injury. Mol Med Rep. 16:1759–1770. 2017. View Article : Google Scholar : PubMed/NCBI
16	Krishnamoorthy K and Subramaniam P: Phytochemical profiling of leaf, stem, and tuber parts of Solena amplexicaulis (Lam.) Gandhi using GC-MS. Int Sch Res Notices. 2014:5674092014.PubMed/NCBI
17	Huang JH, Huang XZ, Chen ZY, Zheng QS and Sun RY: Dose conversion among different animals and healthy volunteers in pharmacological study. Chin J Clin Pharmacol Therap. 9:1069–1072. 2004.
18	Henriques JP, Zijlstra F, van 't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, Hoorntje JC and Suryapranata H: Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 107:2115–2119. 2003. View Article : Google Scholar : PubMed/NCBI
19	Liu Z, Chen JM, Huang H, Kuznicki M, Zheng S, Sun W, Quan N, Wang L, Yang H, Guo HM, et al: The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway. Metabolism. 65:122–130. 2016. View Article : Google Scholar : PubMed/NCBI
20	Saito N: Letter by Saito regarding article, 'Collateral donor artery physiology and the influence of a chronic total occlusion on fractional flow reserve'. Circ Cardiovasc Interv. 8:e0027942015. View Article : Google Scholar
21	Zhao HW, Qin F, Liu YX, Huang X and Ren P: Antiapoptotic mechanisms of Chinese medicine formula, Guan-Xin-Er-Hao, in the rat ischemic heart. Tohoku J Exp Med. 216:309–316. 2008. View Article : Google Scholar
22	Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, et al: Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA. 110:3507–3512. 2013. View Article : Google Scholar : PubMed/NCBI
23	Elmadhun NY, Sabe AA, Robich MP, Chu LM, Lassaletta AD and Sellke FW: The pig as a valuable model for testing the effect of resveratrol to prevent cardiovascular disease. Ann NY Acad Sci. 1290:130–135. 2013. View Article : Google Scholar : PubMed/NCBI
24	Ikonen TS, Pätilä T, Virtanen K, Lommi J, Lappalainen K, Kankuri E, Krogerus L and Harjula A: Ligation of ameroid-stenosed coronary artery leads to reproducible myocardial infarction-a pilot study in a porcine model. J Surg Res. 142:195–201. 2007. View Article : Google Scholar : PubMed/NCBI
25	Caillaud D, Calderon J, Réant P, Lafitte S, Dos Santos P, Couffinhal T, Roques X and Barandon L: Echocardiographic analysis with a two-dimensional strain of chronic myocardial ischemia induced with ameroid constrictor in the pig. Interact Cardiovasc Thorac Surg. 10:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
26	Tuzun E, Oliveira E, Narin C, Khalil H, Jimenez-Quevedo P, Perin E and Silva G: Correlation of ischemic area and coronary flow with ameroid size in a porcine model. J Surg Res. 164:38–42. 2010. View Article : Google Scholar
27	von Degenfeld G, Raake P, Kupatt C, Lebherz C, Hinkel R, Gildehaus FJ, Münzing W, Kranz A, Waltenberger J, Simoes M, et al: Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol. 42:1120–1128. 2003. View Article : Google Scholar : PubMed/NCBI
28	Eisenman A: Troponin assays for the diagnosis of myocardial infarction and acute coronary syndrome: Where do we stand. Expert Rev Cardiovasc Ther. 4:509–514. 2006. View Article : Google Scholar : PubMed/NCBI
29	Li X, Shao D, Wang G, Jiang T, Wu H, Gu B, Cao K, Zhang J, Qi L and Chen Y: Effects of different LAD-blocked sites on the development of acute myocardial infarction and malignant arrhythmia in a swine model. J Thorac Dis. 6:1271–1277. 2014.PubMed/NCBI
30	Tsaroucha A, Chondrogiannis C, Mani A and Staikou C: Myocardial involvement during ischemia-induced acute liver failure in the pig. J Invest Surg. 26:99–104. 2013. View Article : Google Scholar : PubMed/NCBI
31	Arya DS, Bansal P, Ojha SK, Nandave M, Mohanty I and Gupta SK: Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury. Life Sci. 79:38–44. 2006. View Article : Google Scholar
32	Doganci S, Yildirim V, Bolcal C, Korkusuz P, Gumusel B, Demirkilic U and Aydin A: Sodium nitrite and cardioprotective effect in pig regional myocardial ischemia-reperfusion injury model. Adv Clin Exp Med. 21:713–726. 2012.
33	Elizondo-Montemayor L, Ugalde-Casas PA, Lam-Franco L, Bustamante-Careaga H, Serrano-González M, Gutiérrez NG and Martínez U: Association of ALT and the metabolic syndrome among Mexican children. Obes Res Clin Pract. 8:e79-e872014. View Article : Google Scholar
34	Xu Q, Higgins T and Cembrowski GS: Limiting the testing of AST: A diagnostically nonspecific enzyme. Am J Clin Pathol. 144:423–426. 2015. View Article : Google Scholar : PubMed/NCBI
35	Solymoss BC, Bourassa MG, Fortier A and Théroux P: Evaluation and risk stratification of acute coronary syndromes using a low cut-off level of cardiac troponin T, combined with CK-MB mass determination. Clin Biochem. 37:286–292. 2004. View Article : Google Scholar : PubMed/NCBI
36	Zhang M, Dong W, Lu S, Yu Y, Liu H, Li G, Qiang W, Wang L and Lou J: Study on blood-gas changes in the coronary artery of myocardial ischemia reperfusion injury of rabbit. J Naval Med College. 1:9–12. 1996.In Chinese.
37	Feng YJ, Chen C, Fallon JT, Lai T, Chen L, Knibbs DR, Waters DD and Wu AH: Comparison of cardiac troponin I, creatine kinase-MB, and myoglobin for detection of acute ischemic myocardial injury in a swine model. Am J Clin Pathol. 110:70–77. 1998. View Article : Google Scholar : PubMed/NCBI
38	Ishihara Y and Shimamoto N: Sulfaphenazole attenuates myocardial cell apoptosis accompanied with cardiac ischemia-reperfusion by suppressing the expression of BimEL and Noxa. J Pharmacol Sci. 119:251–259. 2012. View Article : Google Scholar : PubMed/NCBI
39	Qu D, Han J, Ren H, Yang W, Zhang X, Zheng Q and Wang D: Cardioprotective effects of Astragalin against myocardial ischemia/reperfusion injury in isolated rat heart. Oxid Med Cell Longev. 2016:81946902016. View Article : Google Scholar : PubMed/NCBI
40	Pan H, Li D, Fang F, Chen D, Qi L, Zhang R, Xu T and Sun H: Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury. J Cardiovasc Pharmacolm. 58:535–542. 2011. View Article : Google Scholar
41	Zhang Q, Wang G, Yuan W, Wu J, Wang M and Li C: The effects of phosphodiesterase-5 inhibitor sildenafil against post-resuscitation myocardial and intestinal microcirculatory dysfunction by attenuating apoptosis and regulating microRNAs expression: Essential role of nitric oxide syntheses signaling. J Transl Med. 13:1772015. View Article : Google Scholar : PubMed/NCBI
42	Wang ZG, Wang Y, Huang Y, Lu Q, Zheng L, Hu D, Feng WK, Liu YL, Ji KT, Zhang HY, et al: bFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia/reperfusion via the activation of the PI3K/Akt/mTOR pathway. Sci Rep. 5:92872015. View Article : Google Scholar : PubMed/NCBI
43	Liu S, Ai Q, Feng K, Li YB and Liu X: The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways. Apoptosis. 21:1366–1385. 2016. View Article : Google Scholar : PubMed/NCBI
44	Zhai P, Sciarretta S, Galeotti J, Volpe M and Sadoshima J: Differential roles of GSK-3β during myocardial ischemia and ischemia_reperfusion. Circ Res. 109:502–511. 2011. View Article : Google Scholar : PubMed/NCBI
45	Duan J, Guan Y, Mu F, Guo C, Zhang E, Yin Y, Wei G, Zhu Y, Cui J, Cao J, et al: Protective effect of butin against ischemia/reperfusion-induced myocardial injury in diabetic mice: Involvement of the AMPK/GSK-3β/Nrf2 signaling pathway. Sci Rep. 7:414912017. View Article : Google Scholar
46	Nagaoka K, Matoba T, Mao Y, Nakano Y, Ikeda G, Egusa S, Tokutome M, Nagahama R, Nakano K, Sunagawa K, et al: A new therapeutic modality for acute myocardial infarction: Nanoparticle-mediated delivery of Pitavastatin induces cardio-protection from ischemia-reperfusion injury via activation of PI3K/Akt pathway and anti-inflammation in a rat model. PLoS One. 10:e01324512015. View Article : Google Scholar
47	Liu ZJ, Shi ZL, Tu C, Zhang HZ, Gao D, Li CY, He Q, Li RS, Guo YM, Niu M, et al: An activity-calibrated chemical standardization approach for quality evaluation of Salvia miltiorrhiza Bge. RSC Adv. 7:5331–5339. 2017. View Article : Google Scholar
48	Zhou GJ, Wang W, Xie XM, Qin MJ, Kuai BK and Zhou TS: Post-harvest induced production of salvianolic acids and significant promotion of antioxidant properties in roots of Salvia miltiorrhiza (Danshen). Molecules. 19:7207–7222. 2014. View Article : Google Scholar : PubMed/NCBI
49	Fan G, Yu J, Asare PF, Wang L, Zhang H, Zhang B, Zhu Y and Gao X: Danshensu alleviates cardiac ischaemia/reperfusion injury by inhibiting autophagy and apoptosis via activation of mTOR signalling. J Cell Mol Med. 20:1908–1919. 2016. View Article : Google Scholar : PubMed/NCBI
50	Jia LQ, Yang GL, Ren L, Chen WN, Feng JY, Cao Y, Zhang L, Li XT and Lei P: Tanshinone IIA reduces apoptosis induced by hydrogen peroxide in the human endothelium-derived EA.hy926 cells. J Ethnopharmacol. 143:100–108. 2012. View Article : Google Scholar : PubMed/NCBI
51	Zhuang P, Zhang Y, Cui G, Bian Y, Zhang M, Zhang J, Liu Y, Yang X, Isaiah AO, Lin Y, et al: Direct stimulation of adult neural stem/progenitor cells in vitro and neurogenesis in vivo by salvianolic acid B. PLoS One. 7:e356362012. View Article : Google Scholar : PubMed/NCBI
52	Li XL, Liu JX, Li P and Zheng YQ: Protective effect of rosmarinic acid on hypoxia/reoxygenation injury in cardiomyocytes. Zhongguo Zhong Yao Za Zhi. 39:1897–1901. 2014.In Chinese. PubMed/NCBI
53	Jung SH, Seol HJ, Jeon SJ, Son KH and Lee JR: Insulin-sensitizing activities of tanshinones, diterpene compounds of the root of Salvia miltiorrhiza Bunge. Phytomedicine. 16:327–335. 2009. View Article : Google Scholar : PubMed/NCBI
54	Guo C, Yin Y, Duan J, Zhu Y, Yan J, Wei G, Guan Y, Wu X, Wang Y, Xi M and Wen A: Neuroprotective effect and underlying mechanism of sodium danshensu [3-(3,4-dihydroxyphenyl) lactic acid from Radix and Rhizoma Salviae miltiorrhizae = Danshen] against cerebral ischemia and reperfusion injury in rats. Phytomedicine. 22:283–289. 2015. View Article : Google Scholar : PubMed/NCBI
55	Gao Q, Hu X, Jiang XJ, Guo MJ, Ji H, Wang Y and Fan YC: Cardiomyocyte-like cells differentiation from non β-catenin expression mesenchymal stem cells. Cytotechnology. 66:575–584. 2014. View Article : Google Scholar : PubMed/NCBI
56	Li XL, Fan JP, Liu JX and Liang LN: Salvianolic acid A protects neonatal cardiomyocytes against hypoxia/reoxygenation-induced injury by preserving mitochondrial function and activating Akt/GSK-3beta signals. Chin J Integr Med. 1–8. 2017.